Overview

Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To investigate whether tiotropium (Spiriva) improves exercise endurance in patients with COPD
Phase:
Phase 3
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Bromides
Tiotropium Bromide